Your browser doesn't support javascript.
loading
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.
Blobner, Jens; Dengler, Laura; Blobner, Sven; Eberle, Constantin; Weller, Jonathan; Teske, Nico; Karschnia, Philipp; Rühlmann, Katharina; Heinrich, Kathrin; Ziemann, Frank; Greif, Philipp A; Jeremias, Irmela; Wuerstlein, Rachel; Hasselmann, Korbinian; Dorostkar, Mario; Harter, Patrick N; Quach, Stefanie; Stoecklein, Veit; Albert, Nathalie L; Niyazi, Maximilian; Tonn, Joerg-Christian; Thon, Niklas; Christoph Westphalen, Benedikt; von Baumgarten, Louisa.
Afiliación
  • Blobner J; Department of Neurosurgery, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Dengler L; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Blobner S; Department of Neurosurgery, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Eberle C; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Weller J; Medical Faculty Heidelberg, University of Heidelberg, Heidelburg, Germany.
  • Teske N; Department of Neurosurgery, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Karschnia P; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Rühlmann K; Department of Neurosurgery, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Heinrich K; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Ziemann F; Department of Neurosurgery, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Greif PA; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Jeremias I; Department of Neurosurgery, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Wuerstlein R; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Hasselmann K; Comprehensive Cancer Center München (CCC München), LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Dorostkar M; Department of Medicine, Hematology and Oncology Division and Cellular Immunotherapy Program, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Harter PN; Department of Medicine, Hematology and Oncology Division and Cellular Immunotherapy Program, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Quach S; Department of Medicine, Hematology and Oncology Division and Cellular Immunotherapy Program, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Stoecklein V; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Albert NL; Dr. von Haunersches Children Hospital, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Niyazi M; Department of Obstetrics and Gynecology and CCC Munich LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Tonn JC; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Thon N; Department of Medicine, Hematology and Oncology Division and Cellular Immunotherapy Program, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Christoph Westphalen B; Comprehensive Cancer Center München (CCC München), LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • von Baumgarten L; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
Neurooncol Adv ; 5(1): vdad060, 2023.
Article en En | MEDLINE | ID: mdl-37287694
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Alemania